ArticleOncotarget2016

Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.

Peder Rustøen Braadland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.